LEV102
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for LEV102, covering 2024-11-13 to 2024-11-13. Get the full timeline:
Most recent: Clinical Trial Update: LEV102 Topical Gel in Acquired Blepharoptosis [Phase 1, Phase 2]